Informing the pharmaceutical drug development, manufacturing and commercialization industry. CARY, NC – May 31, 2017 – The 2nd edition of Industry Standard Research’s (ISR’s) Oral Dosage Forms Market Overview and Outlook report offers details on how industry utilization rates of seventeen different oral dosage forms will shift over the next five years as new technologies and capabilities … Continued
Informing the pharmaceutical drug development, manufacturing and commercialization industry. CARY, NC – May 31, 2017 – Industry Standard Research (ISR) has released a new report, CRO Quality Benchmarking – Phase IV Service Providers (9th Edition), containing findings focused on service provider selection and evaluation. Kevin Olson, CEO, explains, “Each Phase IV clinical outsourcing need is unique. … Continued
The Phase I CROs received high marks in organization and staff factors Informing the pharmaceutical drug development, manufacturing and commercialization industry. CARY, NC – May 18, 2017 – Industry Standard Research (ISR) has released a new report, CRO Quality Benchmarking – Phase I Service Providers (9th Edition), containing findings focused on service provider selection and evaluation. Kevin Olson, … Continued
Vice President of Market Research at Industry Standard Research Rebecca McAvoy explains how our experiential user data can be used to pick the best service provider for your unique needs. From Life Science Leader: For decision makers whose companies have sophisticated outsourcing processes, using peer-based data can assist in evaluating CROs. Those at larger, more … Continued
